Photo by curology from unsplash
Four ovarian cancer patients with severe plantar palmar erythrodysesthesia or mucositis precluding further therapy from pegylated liposomal doxorubicin on the standard every 4 week schedule were able to be treated… Click to show full abstract
Four ovarian cancer patients with severe plantar palmar erythrodysesthesia or mucositis precluding further therapy from pegylated liposomal doxorubicin on the standard every 4 week schedule were able to be treated on every 2-week schedule without recurrence of plantar palmar erythrodysesthesia or stomatitis.
Keywords:
liposomal doxorubicin;
skin mucosal;
pegylated liposomal;
every week;
reduction skin;
week
Journal Title: Anti-Cancer Drugs
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Anti-Cancer Drugs
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!